CONGRESS|#EHA2021|@JoshuaRichterMD & Fredrik Schjesvold discussed clinical challenges for late stage RRMM pts. Implication of 5 possible treatment options was also debated #mmsm #myeloma pic.twitter.com/kE8zxZbCFx
— Multiple Myeloma Hub (@MM_Hub) June 16, 2021